BIO-TECHNE Corp — Director's Dealing 2023

Dec 14, 2023

SEC Form 4/A — Form 4/A

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-08-15

Reporting Person: Kelderman Kim (Pres. Diagnostics & Genom)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-15	Restricted Stock Units	$	A	8873	Acquired		Common Stock (8873)	Direct
2023-08-15	Stock Options (Right to Buy)	$84.61	A	23881	Acquired	2030-08-15	Common Stock (23881)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F2: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).